AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
48.86
-0.13 (-0.26%)
Aug 24, 2026, 9:31 AM EDT - Market open
AtriCure Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 569.62 | 534.53 | 465.31 | 399.25 | 330.38 | 274.33 | |
Revenue Growth | 13.94% | 14.88% | 16.55% | 20.84% | 20.43% | 32.83% |
Cost of Revenue | 135.01 | 133.75 | 117.78 | 98.88 | 84.44 | 68.47 |
Gross Profit | 434.61 | 400.78 | 347.52 | 300.37 | 245.94 | 205.86 |
Selling, General & Admin | 323.69 | 311.02 | 291.36 | 260.64 | 231.27 | 204.65 |
Research & Development | 98.03 | 99.21 | 96.18 | 73.92 | 57.34 | 48.51 |
Operating Expenses | 421.72 | 410.23 | 387.54 | 334.55 | 288.61 | 253.16 |
Operating Income | 12.89 | -9.45 | -40.01 | -34.18 | -42.67 | -47.3 |
Interest Expense | -5.63 | -5.88 | -6.41 | -6.93 | -4.99 | -4.92 |
Interest & Investment Income | 4.92 | 4.48 | 4.43 | 3.79 | 1.99 | 0.47 |
Currency Exchange Gain (Loss) | 0.68 | 0.68 | -0.33 | -0.03 | -0.54 | -0.37 |
EBT Excluding Unusual Items | 12.09 | -10.16 | -42.31 | -37.35 | -46.2 | -52.11 |
Asset Writedown | - | - | - | - | - | -82.3 |
Legal Settlements | - | - | - | 7.5 | - | - |
Other Unusual Items | - | - | -1.36 | - | - | 184.8 |
Pretax Income | 12.09 | -10.16 | -43.67 | -29.85 | -46.2 | 50.39 |
Income Tax Expense | 1.54 | 1.29 | 1.02 | 0.59 | 0.27 | 0.19 |
Net Income | 10.55 | -11.45 | -44.7 | -30.44 | -46.47 | 50.2 |
Net Income to Common | 10.55 | -11.45 | -44.7 | -30.44 | -46.47 | 50.2 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 48 | 48 | 47 | 46 | 46 | 45 |
Shares Outstanding (Diluted) | 49 | 48 | 47 | 46 | 46 | 46 |
Shares Change | 2.50% | 1.67% | 1.42% | 1.24% | -0.65% | 9.29% |
EPS (Basic) | 0.22 | -0.24 | -0.95 | -0.66 | -1.02 | 1.11 |
EPS (Diluted) | 0.21 | -0.24 | -0.95 | -0.66 | -1.02 | 1.09 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 53.11 | 48.28 | 0.75 | -7.51 | -39.02 | -23.53 |
Free Cash Flow Per Share | 1.09 | 1.01 | 0.02 | -0.16 | -0.85 | -0.51 |
Gross Margin | 76.30% | 74.98% | 74.69% | 75.23% | 74.44% | 75.04% |
Operating Margin | 2.26% | -1.77% | -8.60% | -8.56% | -12.91% | -17.24% |
Profit Margin | 1.85% | -2.14% | -9.61% | -7.62% | -14.06% | 18.30% |
Free Cash Flow Margin | 9.32% | 9.03% | 0.16% | -1.88% | -11.81% | -8.58% |
EBITDA | 33.75 | 11.08 | -21.28 | -19.37 | -30.96 | -36.85 |
EBITDA Margin | 5.92% | 2.07% | -4.57% | -4.85% | -9.37% | -13.43% |
D&A For EBITDA | 20.86 | 20.53 | 18.73 | 14.81 | 11.71 | 10.44 |
EBIT | 12.89 | -9.45 | -40.01 | -34.18 | -42.67 | -47.3 |
EBIT Margin | 2.26% | -1.77% | -8.60% | -8.56% | -12.91% | -17.24% |
Effective Tax Rate | 12.75% | - | - | - | - | 0.37% |
Advertising Expenses | - | 2.23 | 2.82 | 1.7 | 1.23 | 0.91 |